miRNA‐6236 Regulation of Postischemic Skeletal Muscle Angiogenesis

Background Peripheral arterial disease affects >200 million people worldwide and is characterized by impaired blood flow to the lower extremities. There are no effective medical treatments available. Using the mouse hind‐limb ischemia model and miRNA sequencing, we identified a novel miRNA, miR‐6...

Full description

Saved in:
Bibliographic Details
Main Authors: Arul M. Mani, Victor Lamin, Ronan C. Peach, Eli H. Friesen, Thomas Wong, Madhu V. Singh, Ayotunde O. Dokun
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.035923
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846142495033917440
author Arul M. Mani
Victor Lamin
Ronan C. Peach
Eli H. Friesen
Thomas Wong
Madhu V. Singh
Ayotunde O. Dokun
author_facet Arul M. Mani
Victor Lamin
Ronan C. Peach
Eli H. Friesen
Thomas Wong
Madhu V. Singh
Ayotunde O. Dokun
author_sort Arul M. Mani
collection DOAJ
description Background Peripheral arterial disease affects >200 million people worldwide and is characterized by impaired blood flow to the lower extremities. There are no effective medical treatments available. Using the mouse hind‐limb ischemia model and miRNA sequencing, we identified a novel miRNA, miR‐6236, whose expression significantly elevated in ischemic mouse limbs compared with nonischemic limbs. The role of miR‐6236 in general or in postischemic angiogenesis is not known. Here we describe its role using in vivo and in vitro models of peripheral arterial disease. Methods and Results In primary mouse and human endothelial cells, we studied the effect of simulated ischemia on miR‐6236 expression and assessed its role in cell viability, apoptosis, migration, and tube formation during ischemia. Furthermore, we developed miR‐6236 null mice and tested its role in postischemic perfusion recovery using the hind‐limb ischemia model. Lastly, using bioinformatics and gene expression analysis, we identified putative angiogenic miR‐6236 targets. In vitro simulated ischemia‐enhanced miR‐6236 expression in mouse and human endothelial cells, whereas its inhibition improved viability, migration, tube formation, and reduced apoptosis. In vivo ischemic mouse skeletal muscle tissue showed higher miR‐6236 expression compared with nonischemic muscles. Loss of miR‐6236 improved impaired postischemic perfusion recovery and poor angiogenesis associated with streptozotocin‐induced diabetes in mice. Six of the 8 miR‐6236 predicted angiogenic target mRNAs showed expression consistent with regulation by miR‐6236 in ischemic skeletal muscle. Conclusions Our results show for the first time that miR‐6236 plays a key role in regulating postischemic perfusion recovery and angiogenesis.
format Article
id doaj-art-97219a33abd14408be23f06bfe1baf85
institution Kabale University
issn 2047-9980
language English
publishDate 2024-12-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj-art-97219a33abd14408be23f06bfe1baf852024-12-03T10:06:25ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802024-12-01132310.1161/JAHA.124.035923miRNA‐6236 Regulation of Postischemic Skeletal Muscle AngiogenesisArul M. Mani0Victor Lamin1Ronan C. Peach2Eli H. Friesen3Thomas Wong4Madhu V. Singh5Ayotunde O. Dokun6Division of Endocrinology and Metabolism, Carver College of Medicine University of Iowa Iowa City IA USADivision of Endocrinology and Metabolism, Carver College of Medicine University of Iowa Iowa City IA USADivision of Endocrinology and Metabolism, Carver College of Medicine University of Iowa Iowa City IA USADivision of Endocrinology and Metabolism, Carver College of Medicine University of Iowa Iowa City IA USADivision of Endocrinology and Metabolism, Carver College of Medicine University of Iowa Iowa City IA USADivision of Endocrinology and Metabolism, Carver College of Medicine University of Iowa Iowa City IA USADivision of Endocrinology and Metabolism, Carver College of Medicine University of Iowa Iowa City IA USABackground Peripheral arterial disease affects >200 million people worldwide and is characterized by impaired blood flow to the lower extremities. There are no effective medical treatments available. Using the mouse hind‐limb ischemia model and miRNA sequencing, we identified a novel miRNA, miR‐6236, whose expression significantly elevated in ischemic mouse limbs compared with nonischemic limbs. The role of miR‐6236 in general or in postischemic angiogenesis is not known. Here we describe its role using in vivo and in vitro models of peripheral arterial disease. Methods and Results In primary mouse and human endothelial cells, we studied the effect of simulated ischemia on miR‐6236 expression and assessed its role in cell viability, apoptosis, migration, and tube formation during ischemia. Furthermore, we developed miR‐6236 null mice and tested its role in postischemic perfusion recovery using the hind‐limb ischemia model. Lastly, using bioinformatics and gene expression analysis, we identified putative angiogenic miR‐6236 targets. In vitro simulated ischemia‐enhanced miR‐6236 expression in mouse and human endothelial cells, whereas its inhibition improved viability, migration, tube formation, and reduced apoptosis. In vivo ischemic mouse skeletal muscle tissue showed higher miR‐6236 expression compared with nonischemic muscles. Loss of miR‐6236 improved impaired postischemic perfusion recovery and poor angiogenesis associated with streptozotocin‐induced diabetes in mice. Six of the 8 miR‐6236 predicted angiogenic target mRNAs showed expression consistent with regulation by miR‐6236 in ischemic skeletal muscle. Conclusions Our results show for the first time that miR‐6236 plays a key role in regulating postischemic perfusion recovery and angiogenesis.https://www.ahajournals.org/doi/10.1161/JAHA.124.035923angiogenesisendothelial cellsischemiamiR‐6236peripheral arterial disease
spellingShingle Arul M. Mani
Victor Lamin
Ronan C. Peach
Eli H. Friesen
Thomas Wong
Madhu V. Singh
Ayotunde O. Dokun
miRNA‐6236 Regulation of Postischemic Skeletal Muscle Angiogenesis
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
angiogenesis
endothelial cells
ischemia
miR‐6236
peripheral arterial disease
title miRNA‐6236 Regulation of Postischemic Skeletal Muscle Angiogenesis
title_full miRNA‐6236 Regulation of Postischemic Skeletal Muscle Angiogenesis
title_fullStr miRNA‐6236 Regulation of Postischemic Skeletal Muscle Angiogenesis
title_full_unstemmed miRNA‐6236 Regulation of Postischemic Skeletal Muscle Angiogenesis
title_short miRNA‐6236 Regulation of Postischemic Skeletal Muscle Angiogenesis
title_sort mirna 6236 regulation of postischemic skeletal muscle angiogenesis
topic angiogenesis
endothelial cells
ischemia
miR‐6236
peripheral arterial disease
url https://www.ahajournals.org/doi/10.1161/JAHA.124.035923
work_keys_str_mv AT arulmmani mirna6236regulationofpostischemicskeletalmuscleangiogenesis
AT victorlamin mirna6236regulationofpostischemicskeletalmuscleangiogenesis
AT ronancpeach mirna6236regulationofpostischemicskeletalmuscleangiogenesis
AT elihfriesen mirna6236regulationofpostischemicskeletalmuscleangiogenesis
AT thomaswong mirna6236regulationofpostischemicskeletalmuscleangiogenesis
AT madhuvsingh mirna6236regulationofpostischemicskeletalmuscleangiogenesis
AT ayotundeodokun mirna6236regulationofpostischemicskeletalmuscleangiogenesis